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Introduction
Adverse pregnancy outcomes are reported to cause up to 70% 
of all perinatal deaths1,2 with 30% due to clinical or subclinical 
infection.3 Between 25–50% occur without any known etiology4 
and in the absence of confounding factors.5 Life-long complica-
tions due to preterm birth (PTB) such as abnormalities in sight 
and hearing, developmental retardation and neurological com-
plications have been reported,6,7 resulting in health care costs 
exceeding 10 times the costs of infants born full-term (FTB).
The term “adverse pregnancy outcomes” includes many dif-
ferent categorizations. Preterm labor (PTL) and preterm birth 
(PTB) are defined as labor before 37 weeks gestation and in 
30% of cases, is preceded by premature (<37 weeks gestation) 
rupture of membranes (PPROM). Previously, all infants born 
weighing <2,500 g were considered to be premature but now, 
with the advent of better gestational dating, it was found that 
not all infants born of low birth-weight (LBW) are in fact born 
prematurely. LBW does not distinguish between PTB and FTB 
infants, nor does it provide information on gestational age, yet 
the term premature low birth-weight (PTLBW) is often used to 
include infants born “small for gestational age” (SGA). SGA is a 
categorization for infants of all gestational ages achieved by the 
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Background: Preterm birth significantly impacts on neonatal 
morbidity and mortality and is apparently increasing world-
wide. Several studies have attempted to define a causative role 
for periodontal disease in adverse pregnancy outcomes but 
few have focused on the microbiology of periodontal disease 
in relation to these outcomes.
results: The evidence for a positive correlation is strong, 
supported by microbiological and immunological findings. 
Conflicting results are often associated with uncontrolled con-
founding factors.
Materials and Methods: A literature search was conducted 
in order to establish whether or not a role exists for oral Gram-
negative bacteria in adverse pregnancy outcomes. Association 
and intervention studies are summarized along with patho-
genic potential of the Gram-negative bacteria most frequently 
implicated in periodontal disease.
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establishment of growth curves and detailed statistics for infants 
falling within the lowest 10th percentile at a given date of deliv-
ery. Their small size is attributed to intrauterine growth restric-
tion (IUGR).8 Sources of infection linked to adverse pregnancy 
outcomes include intrauterine, lower genital tract and systemic 
infections. Periodontal disease has also been implicated as a risk 
factor for adverse pregnancy outcomes and refers to a group of 
endogenous polymicrobial infections that cause inflammation 
and destruction of the gingiva (gingivitis) and other support-
ing structures of the tooth such as the periodontal ligament and 
alveolar bone (periodontitis).9 No overt pathogen has been iden-
tified, but its etiology is strongly associated with anaerobic Gram-
negative bacilli.10,11 This review will focus on the association of 
the anaerobic Gram-negative bacteria implicated in periodontal 
disease and examine their potential to cause adverse pregnancy 
outcomes.
Results
Studies displayed heterogeneity concerning diagnostic criteria of 
periodontal disease and types of pregnancy outcome, so no meta-
analysis was performed.
Risk factors for adverse pregnancy outcomes. There are sev-
eral risk factors associated with adverse pregnancy outcomes, 
including prenatal care,12-14 age,15,16 smoking,17-21 a history of pre-
vious preterm delivery,13,15,22-27 educational level,13,28 poor nutri-
tion,27,29 maternal weight and height,26,27,30-33 first pregnancy,34 
depression,35 social stress factors,16,36 antibiotic usage,37,38 alcohol 
and drug abuse39,40 and infection and inflammation.41-43 Recently, 
a genetic predisposition for PTB has been proposed, either due 
to racial disparities that are independent of socio-economic fac-
tors,25 or as part of the gene-environmental interaction associated 
with either hypo-or hyper-immune responses.44
In order to establish whether periodontal disease and/or other 
endogenous infections may pose a risk for PTB and other preg-
nancy outcomes, it is important to understand how the dental 
plaque bacterial biofilm forms and why pregnant mothers are at 
risk for developing periodontal disease.
The bacterial plaque biofilm in pregnancy-associated peri-
odontal disease. The tooth surface harbors a microbial popu-
lation that lives in harmony with the host tissues and protects 
by occupying an ecological niche that would otherwise be colo-
nized by potentially pathogenic bacteria.45 The relatively aerobic 
environment of the healthy gingival sulcus tends to preclude the 
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the world with some researchers reporting a significant associa-
tion between periodontal disease and adverse pregnancy out-
comes in, among others, Thailand,65,66 Saudi Arabia,67 Turkey,68 
Brazil,14,69 Venezuela,70 Chile,71 Senegal,72 South Africa,73 
Hungary,74,75 Croatia,76 Finland,32 USA,24,77-80 Austria,81 Taiwan13 
and Japan.82 No association and/or contradictory outcomes were 
reported from countries such as Sri Lanka,83 Pakistan,84 Turkey,85 
England,86-89 Germany,15 Iceland,90 Tanzania,16 Rwanda,26 
Brazil91-93 or Chile.94 These include both case-control and cohort 
studies. In case-control studies, mothers who experience adverse 
pregnancy outcomes such as PTB, LBW or PTLBW are exam-
ined for periodontal disease, while in cohort studies, mothers are 
investigated over a period of time in order to establish whether 
those with periodontal disease will demonstrate a higher inci-
dence of adverse pregnancy outcomes than those without peri-
odontal disease. However, very few of these studies examined 
for a microbial etiology and associations were largely based on 
clinical evaluations of periodontal disease. Differences in diag-
nosis, clinical measurements, stage of gestation, disease activity 
and severity, treatment programmes, along with the confounding 
factors listed above may affect disease progression and pregnancy 
outcome. These factors may explain different outcomes in popu-
lations from the same geographical area as demonstrated in the 
Brazilian studies.14,69,91-93
Microbial complexes in subgingival plaque and their asso-
ciation with PTB. In order to study a relationship between two 
events, it is imperative to establish an association first, bearing in 
mind that the association could easily be due to chance, bias, and/
or confounding factors. This is especially relevant in attempting 
to determine a relationship between the complex communities 
of periodontopathogens and pregnancy outcomes. The following 
selection of some of the most frequently cited studies examining 
for the relationship between periodontal disease and PTB clearly 
demonstrates this.
Gram-negative anaerobes frequently implicated in pregnancy 
periodontal disease include members of the Orange and Red 
complexes described by Socransky et al.95,96 Using cluster analysis, 
Socransky and his colleagues identified six complexes of bacteria 
which commonly occur together, and color-coded them as Blue, 
Green, Yellow and Purple, Orange and Red with the latter two 
complexes implicated as etiological agents in periodontal disease 
and therefore as risk factors for adverse pregnancy outcomes.81 
The Orange complex includes species such as Campylobacter rec-
tus, Peptostreptococcus micros, Prevotella nigrescence, Fusobacterium 
nucleatum and Prevotella intermedia and provides the lawn for 
the attachment and colonization of members of the Red com-
plex (Tannerella forsythia, Treponema denticola, P. gingivalis). 
Although clustered within the Green complex, Capnocytophaga 
and Aggregatibacter actinomycetemcomitans (Aa) have frequently 
been associated with periodontal disease and with PTB and are 
therefore included in this review.
Orange and Red complexes have been reported in 16–18% 
of FTB and 80–100% of PTB.81,97 As with the clinical asso-
ciations between periodontal disease and PTB, inconsistencies 
occur when comparing PTB and FTB for associated bacteria. 
Significant differences have been reported in the association of 
growth of obligate anaerobes and the predominant cultivable flora 
includes facultative anaerobes, predominantly Gram-positive 
rods and cocci. If plaque is allowed to accumulate, demonstrable 
inflammation of the gingiva will occur in 2–4 days due to the 
production of various noxious metabolites such as endotoxins, 
lipoteichoic acids, mucopeptides, metabolic end products and 
proteolytic agents as well as a host of other enzymes such as hyal-
uronidase and chondroitinase, which may penetrate the gingival 
tissues causing their destruction by direct injury or by stimula-
tion of inflammatory immune responses which, in turn, results 
in their further destruction.46 In addition, plaque accumulation 
may be facilitated by the increased production of gingival cre-
vicular fluid which contains growth-promoting factors for a wide 
range of bacteria including Gram-negative anaerobes such as 
P. gingivalis, Prevotella intermedia and Fusobacterium nucleatum, 
among the bacteria known to be increased in pregnant women 
and women taking oral contraceptives.47-50
Hormonal and vascular changes associated with pregnancy 
may exacerbate the gingival response to bacterial plaque, result-
ing in an inflammatory periodontal disease. Pregnancy gingivitis 
is the most common oral manifestation of pregnancy and comes 
about as a result of the hormones estrogen and progesterone, and 
not necessarily because of an increase in plaque bacteria.49 It is 
reported to affect between 30–100% of pregnant women.51-55 
Pregnancy gingivitis usually occurs in the second month of ges-
tation and progresses with time, reaching a pe k in the eighth 
month of gestation. It usually subsides thereafter and immedi-
ately postpartum may revert to what was previously observed in 
the mouth.51,56
Several factors are thought to play a role in the establishment 
of pregnancy gingivitis. The increased hormonal levels enhance 
localized production of inflammatory mediators such as prosta-
glandin E
2
 (PGE
2
),57 while progesterone also reduces fibroblast 
proliferation, alters collagen production and reduces the level of 
plasminogen activator inhibitor type-2 (PAI-2), an important 
inhibitor of tissue proteolysis.48,58
Repeated vomiting during pregnancy results in acid-induced 
erosion, and coupled with the inability to tolerate toothbrush-
ing because of tooth sensitivity and nausea, the oral hygiene of 
the pregnant woman is severely compromised.56,59,60 This, along 
with estrogen-enhanced proliferation and desquamation of the 
oral mucosa and nutrients provided by the bleeding gingiva cre-
ates a suitable environment for an overgrowth of Gram-negative 
anaerobes in the plaque.47-50,61,62
Association of periodontal disease with PTB. Among the 
first studies to associate a periodontopathogen with pregnancy 
outcomes was the study by Collins and colleagues,63 who injected 
pregnant hamsters with Porphyromonas gingivalis (an oral anaer-
obe commonly associated with periodontal disease), and proved 
that oral bacteria and the inflammatory mediators produced in 
response to the antigens they present, could disseminate via the 
bloodstream to the maternal-fetal interface and induce adverse 
pregnancy outcomes. A human association study followed,64 
which demonstrated that mothers with periodontal disease were 
more likely to deliver PTLBW infants than mothers with good 
oral health. This sparked off a series of association studies around 
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periodontopathogens in non-susceptible controls resulted in 
elevated antibody levels considered to prevent infection in con-
trols while challenge with increased numbers of pathogens may 
overwhelm acquired immunity resulting in reduced antibody 
levels with a reduced protection against infection, thus allowing 
for hematogenous spread of Gram-negative species to the fetal-
maternal interface.102
Intrauterine infections as a risk factor for PTB. PTB due to 
intrauterine infection was reported to be rare beyond 34 weeks 
gestation with 45% occurring between 23 and 26 weeks gesta-
tion, 16% occurring at 27–30 weeks gestation and 11% at 31–34 
weeks gestation.103 The demonstration of any bacteria in the 
normally sterile amniotic cavity would be indicative of bacterial 
invasion, and because bacteria are more frequently isolated from 
the chorioamniotic space than from amniotic fluid, it would sug-
gest that microbial invasion of the amniotic cavity results from 
advancing disease from the extra-amniotic to the intra-amniotic 
space.104-106
Proposed pathways of intrauterine infections include the 
ascending route (following genital endogenous or exogenous 
infections) and hematogenous spread and translocation of bacte-
ria from distant body sites to the fetal-placental unit.107
Infection via the ascending route. Romero et al.106 proposed 
the following ascending pathway for infection. It starts with 
vaginal colonization of exogenous pathogens or an overgrowth 
of endogenous opportun stic microflora, followed by infection 
of either the intra- or extra-amniotic space, depending on the 
location of the infective agent. Extra-amniotic infection occurs 
when bacteria reside in the deciduas resulting in a localized 
inflammatory reaction which leads to deciduitis and extending 
to chorionitis. Fetal vessels may be invaded or the infection may 
proceed through the amnion into the amniotic cavity, resulting 
in an intra-amniotic infection. Entry of microorganisms into the 
intra-amniotic space is not dependent on rupture of membranes 
as microbes have been able to cross intact membranes.108 Once 
bacteria have gained access to the amniotic cavity and infected 
the amniotic fluid, they have direct access to the fetus who is 
then infected by aspiration of the infected fluid leading to con-
genital pneumonia, or the microbes in the infected fluid may 
directly invade the fetus causing localized infections such otitis 
or conjunctivitis. Bacteremia and/or septicemia may occur fol-
lowing any seeding from these localized infections to the fetal 
circulation.
Goldberg et al.109 reported that up to 80% of women who 
deliver preterm produced evidence of ascending bacterial infec-
tion in the amniotic fluid or membranes, with predominant 
organisms being those associated with bacterial vaginosis (BV), 
a condition brought about by an imbalance and shift of the nor-
mal vaginal flora in favor of anaerobic bacteria. When compar-
ing women with BV and without gingivitis with those who had 
BV plus gingivitis, increased vaginal counts were observed in the 
latter.110 This could indicate an association between BV and peri-
odontal disease with PTB since both conditions occur frequently 
during pregnancy, both come about as a result of a shift in endog-
enous microflora from predominantly facultative organisms to 
predominantly anaerobic organisms and they share common 
the Orange and Red complexes (along with Aa and F. nucleatum) 
with PTB in some studies81,98 while in others, no association was 
demonstrated.99
The prevalence of members of the Red and Orange com-
plexes,81 were reported to occur in the order of T. forsyth-
ia,15,26,75,81,82,98,100,101 T. denticola98,100 and P. gingivalis.75,98 In 
the Orange complex, C. rectus85,98,101 P. intermedia,15,26,75,98 
P. micros85,100 and F. nucleaturm15,75,85,98,100 were most frequently 
reported, with Aa75,98,100 Capnocytophaga75,100 S. intermedius,85,100 
E. corrodens and Selenomonas85 being significantly increased in 
some case studies but not in others, even though their levels were 
seen to increase considerably in PTB.
In other cases where periodontal disease was evident15,26 and 
members of the Red and Orange complexes were detected in sub-
gingival plaque15,99 or gingival crevicular fluid,26 no differences 
between PTB and FTB were found, nor were any Red complex 
bacteria detected in the absence of the Orange complex in any of 
these studies, confirming that colonization of the Orange com-
plex is a prerequisite for the Red complex to become established.
A lack of association with periodontal measurements in a 
Danish population of PTB and FTB mothers failed to support 
an association between periodontal disease and PTB although 
an association of PTB with increased prevalence of S. interme-
dius, S. sanguinis and S. oralis, usually considered to be primary 
colonizers of the plaque biofilm and not usually associated with 
periodontal disease, was established.100 Even though their role in 
periodontal disease has not been clearly established, streptococci 
have been associated with adverse pregnancy outcomes through 
DNA analysis of amniotic fluid.22
Maternal and fetal immunoglobulin levels and their associa-
tion with PTB. The possibility that periodontal disease could 
contribute to PTB is further supported by host responses to 
the Gram-negative bacteria implicated in periodontal disease. 
Examination of serum IgG provides evidence for both systemic 
exposure and protection by facilitating clearance. A finding of 
IgM would demonstrate in utero exposure to periodontopatho-
gens and therefore fetal exposure. Periodontal pathogens and 
their antibodies may be found not only in subgingival plaque 
samples and gingival crevicular fluid but also in maternal serum 
or plasma, amniotic fluid and placenta. As with the detection 
of subgingival colonizers above, mothers who were seropositive 
(Immunoglobulin G, IgG) for Red complex bacteria (98%), were 
also positive for Orange complex bacteria and IgG responses were 
found to parallel colonization of the Orange complex in advance 
of the Red complex.99 Maternal IgG responses showed a signifi-
cant reduction in anti-P. gingivalis IgG in PTB compared with 
FTB.98
Another case-control study24 showed no differences between 
PTB and FTB in maternal IgG for Red and Orange complexes, 
although a clinical correlation with PTB was established. A lack 
of maternal IgG response to members of the Red complex and 
other oral flora implicated in PTB may result in fetal exposure 
thus suggesting that maternal IgG may protect against both 
fetal exposure and PTB, while increased cord blood IgM may 
suggest in utero exposure of the fetus to maternal oral organ-
isms. The literature suggests that colonization of suspected 
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suggesting that the infection originated from her oral cav-
ity and was hematogenously spread to the uterus rather than 
via the ascending route from the vagina following oral-genital 
transmission.
Other oral bacteria associated with human intrauterine infec-
tions include Aa,129 Campylobacter,99,130,132 Eikenella133,134 and 
Leptotrichia.133
Virulence properties of subgingival plaque colonizers. It has 
been proposed that microbial studies should identify potential 
virulence factors of oral bacterial colonizers which may relate to 
placental targeting fetal exposure and growth restriction before 
any finite conclusion can be drawn regarding the association 
between PTB and periodontal disease.99
Virulence properties of F. nucleatum include co-aggregative 
and synergistic mechanisms.135 This is an important factor in 
biofilm formation as it creates an environment which favors 
the colonization of other anaerobes such as the Red complex 
(T. forsythia, P. gingivalis, T. denticola), Prevotella and Aa.136-138 Its 
FadA adhesin and invasive mechanism allows it to colonize and 
infect the placenta.119,121 Other pathogenic mechanisms include 
phospholipase and endotoxin activity which contribute to PTB.
Campylobacter species are known to cross the placenta and 
induce adverse pregnancy outcomes in sheep139 and IUGR in 
mice.140 C. rectus, P. gingivalis, Prevotella, Aa and their bacterial 
products are among the periodontopathogens reported to dis-
seminate from the oral cavity through the circulatory system to 
the uterus thus inducing systemic and inflammatory responses 
which bring about PTB.99,141-143 They also produce proteases 
which reduce chorioamniotic membrane strength and very high 
bacterial loads may weaken fetal membrane strength resulting in 
preterm rupture of membranes.144
Phospholipase A2, a precursor of prostaglandin synthesis, is 
produced by Bacteroides, Pepstostreptococcus, Fusobacterium 
and Gardnerella vaginalis.144,145 Lysosomes in fetal membrane 
cells contain high concentrations of phospholipase A2 and their 
destruction within decidual or chorioamnion cells may trigger 
prostaglandin synthesis resulting in uterine contractions.
Treponema have the ability to invade, cross the placenta and 
infect the fetus146 and present a risk for both PTB and still birth, 
especially in low income societies.147 These findings demonstrate 
the virulence mechanisms of bacteria implicated in periodontal 
disease and along with the host response to these mechanisms 
in the section that follows, may suggest a role for the Orange 
and Red microbial complexes in the pregnancy outcomes of a 
susceptible host, particularly for those species showing clonal 
heterogeneity.
Inflammatory responses due to microbial products. During 
pregnancy, innate pro-inflammatory immune responses are 
strictly regulated within the uterus thus preventing immu-
nological rejection of the fetal allograph. If bacteria and their 
toxins enter the uterine cavity via the ascending route from the 
lower genital tract, or if they invaded the chorioamniotic space, 
thereby disrupting this delicate balance and activating fetal 
membranes, this could lead to the maternal immune response 
being triggered to produce a vast array of cytokines and growth 
factors at the maternal-fetal interface. This, in turn, may elicit 
bacterial co-colonizers such as Prevotella, Porphyromonas, 
Bacteroides, Peptostreptococcus and Fusobacterium.111
Infection via translocation of bacteria. Other ways by which 
bacteria may gain access to the amniotic cavity include hematog-
enous spread and translocation of bacteria to the feto-placental 
unit.107
The focal infection theory of Miller112 states that oral micror-
ganisms and/or their end products are able to gain entrance to, 
and infect, neighboring or distant parts of the body. Because not 
all women who experience PTB have genital infections, and not 
all with genital infections deliver preterm, the possibility exists 
that the oral cavity may be a source of infection for adverse preg-
nancy outcomes113 especially since a common pathophysiology 
exists due to microbial similarities between the female genital 
tract and the oral cavity.44
F. nucleatum has been associated with PLBW75,114 and is one 
of the most common isolates from amniotic fluid of patients with 
PTB and intact membranes115-117 and in one study it was dem-
onstrated that the F. nucleatum isolate clearly matched species 
isolated from the mouth than from the genital tract.118 Although 
it may be conceded that F. nucleatum enters the amniotic space as 
a result of ascending infection following oral-genital transfer, fur-
ther studies demonstrated hematogenous spread.118,119 Pregnant 
mice were injected with F. nucleatum, inducing infection that 
was restricted to the uterus causing Toll-like receptor 4-mediated 
localized inflammatory responses which resulted in PTB, still-
births and non-sustained live births without spreading systemi-
cally.98,119 This same group later demonstrated similar findings 
in a human case study of a stillbirth from a mother with preg-
nancy gingivitis, who developed a respiratory infection at term.120 
Examination of oral, vaginal and rectal flora, showed that the 
clone in her subgingival plaque matched the clone found in the 
placenta and stillborn infant but differed from that found in her 
supragingival plaque, vagina or rectum. It was then speculated 
that because of the weakening of the maternal immune system 
during the respiratory infection, it allowed for translocation of 
F. nucleatum from the mother’s mouth to the uterus. Its ability 
to colonize the placenta and chorioamniotic membranes in PTB 
is facilitated by its most powerful virulence mechanism, namely, 
the FadA adhesin.121
An association between microbial DNA and complications 
during pregnancy, including a history of miscarriage, intrauter-
ine and neonatal death, PTB and premature rupture of mem-
branes have been associated with the presence of F. nucleatum 
and streptococci in amniotic fluid.22
Capnocytophaga has been isolated in pure culture from 
amniotic fluid,122 infant blood123,124 placenta125 maternal blood126 
uterus,123,127 infant gastric aspirate124,127 and endometrium.124 Its 
isolation from mothers with ruptured membranes was often asso-
ciated with infant respiratory failure. Capnocytophaga may be 
implicated in occult causes of chorioamnionitis or PTB with the 
prevalence being much higher than was previously reported.128–130.
Direct evidence of oral-utero microbial transmission was 
demonstrated in a patient with an intrauterine infection caused 
by a hitherto uncultivated Bergeyella species.131 The same strain 
was detected in her subgingival plaque but not in her vagina, 
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while IL-1β and IL-8 were reported to be significantly increased 
in a Japanese population.82
Intervention studies. Periodontal disease is both treatable and 
preventable and thus it would be expected that periodontal treat-
ment/intervention during pregnancy would improve pregnancy 
outcomes171,172 thereby reducing the risk of fetal exposure173 and 
in turn, strengthening the argument in favor of the role played by 
periodontal disease in adverse pregnancy outcomes.163,174-176
A 28% reduction in PLBW was associated with treatment 
in a study of women with predominantly low socio-economic 
backgrounds (60% African-American, 39% Hispanic).101 The 
group who received oral prophylaxis during pregnancy had an 
incidence of 13.5% PLBW, while the control group who were 
recruited postpartum showed 18.9% PLBW. This difference was 
not statistically different although elevated levels of T. forsythia 
and C. rectus were observed in plaque from PLBW mothers.
The successful use of antibiotics for treatment to reduce the 
risk for adverse pregnancy outcomes in mothers with either BV or 
periodontal disease, yielded conflicting results33,177-185 and in fact, 
one study185 demonstrated an increase in PTB following metroni-
dazole administration.
In a randomized control trial,186 a sample population was 
divided into four groups with Group 1 = prophylaxis + placebo, 
Group 2 = scaling and root planing + placebo, Group 3 = scal-
ing and root planning + metronodazole and Group 4 = controls. 
Results showed that s aling and root planing reduced PTB while 
the addition of metronidazole did nothing to improve pregnancy 
outcomes.
Comparison of treatment before 28 weeks gestation was 
compared with treatment postpartum in a randomized study in 
Chile.174 Treatment consisted of oral hygiene instruction, scal-
ing and root planning, plus a daily dose of Chlorhexidine mouth 
rinse. They reported a 82% reduction in PLBW. A later study 
by the same group,187 further proved that mechanical debride-
ment on its own was not as effective as with the adjunct use of 
Chlorhexidine in reducing PTB. Treatment was initiated in the 
second trimester and continued into the third trimester. Scaling 
and root planning in the second trimester of pregnancy showed 
no success in reducing PTB,171,172 and was instead associated with 
elevated proportions of the Red complex.98
Women with periodontal disease, hospitalized because of the 
threat of PTB, were randomly assigned to two groups; one group 
received treatment for periodontal disease by way of oral hygiene 
instruction, scaling and root planing plus fluoride polishing while 
the other group received no treatment.188 Treatment was provided 
in the third trimester. A significant difference in gestational age 
and weight of their infants was observed with those who had 
been treated delivering at 37.5 weeks with a weight of 3,079 g, 
while the untreated mothers delivered at 36.1 weeks with a birth-
weight of 2,602 g. From these studies, it would appear that treat-
ment during the third trimester was more beneficial to the patient 
than treatment in the second trimester.
There is the threat that mechanical debridement in the 
absence of a concurrent administration of an antimicrobial agent, 
might result in a bacteremia192 the degree of which correlates 
with the severity of periodontal disease193-195 inciting an acute 
an inflammatory burden that may damage the placenta resulting 
in fetal growth restriction (FGR). Added to that, the maternal 
cytokine responses may lead to the stimulation of prostaglandin 
synthesis, particularly E
2
 (PGE
2
) and the release of metallopro-
teinases (MMPs), which bring about uterine contractions and 
membrane rupture, thereby prematurely activating the parturi-
tion mechanism resulting in PTB, PPROM and LBW.148
It was postulated that periodontal infections are able to pro-
duce local and systemic host responses, leading to transient bac-
teremia.149 Lipopolysaccharide (LPS), an endotoxin released by 
Gram-negative bacteria implicated in the etiology of periodon-
tal disease, along with other bacterial products gain access to 
gingival tissue where they initiate and perpetuate local inflam-
matory reactions including the production of pro-inflammatory 
cytokines. These maternal inflammatory responses play an 
important role in the pathophysiology of adverse pregnancy 
outcomes.65,104,150,151 Gingival crevicular fluid (GCF) levels of 
PGE
2
 and interleukin-1β (IL-1β) are significantly elevated in 
PTB.152,153 The bacteria from subgingival plaque along with 
LPS and pro-inflammatory cytokines from the inflamed gingi-
val tissue can enter the bloodstream, reach the maternal-fetal 
interface and trigger or exacerbate the maternal inflammatory 
response increasing plasma levels of prostaglandin and cyto-
kines such as IL-1β, tumor necrosis factor-α (TNFα), IL-6 and 
PGE
2
.18,24,82,150,154-156 PGE
2
 is responsible for mediating cervical 
ripening and stimulating uterine contractions and thus PTB is 
initiated.
Associations of elevated levels of IL-6 in maternal blood and 
amniotic fluid in cases of PTB have suggested a role for IL-6 as an 
indicator of intrauterine infection and a predictor of PTB.3,157-161 
It has also earned the role of diagnostic marker in periodontal 
disease.162,163 A study of murine maternal responses to P. gingi-
valis during pregnancy164 showed that P. gingivalis dissemination 
to the uterus has to occur for fetal growth retardation (FGR). 
Maternal humoral responses demonstrated elevated IgG and 
TNFα in FGR fetuses. P. gingivalis LPS challenge immunization 
was found to enhance effects on growth restriction rather than 
offer protection for the fetus, probably due to exacerbation of the 
inflammatory response. IL-6 and TNFα levels were elevated in 
the PTB group while anti-inflammatory IL-10 decreased signifi-
cantly. Increased IL-6 and reduced amniotic fluid levels of IL-10 
in the second trimester was also considered to be an indicator of 
PTB in humans.157 IL-10 is important for regulating the balance 
between innate inflammatory responses and acquired humoral 
responses. Contradictions in the literature create confusion 
regarding the role of IL-10 in PTB and its apparent multifari-
ous role at the maternal-fetal interface remains controversial.165 
Reduced levels of IL-10 in PTB3,166 and periodontal disease167,168 
associated with elevated levels of IL-6 were reported to promote 
PTB, while a protective role for elevated levels of IL-10 in pre-
venting PTB has also been proposed.169,170
Amniotic fluid levels of IL-6 and PGE
2
 were significantly 
elevated in PTB and correlated well with bacterial plaque cul-
tures in a study by Dortbudak et al.81 while IL-8 was significantly 
increased in FTB. No difference was found between PTB and 
FTB for amniotic fluid levels of TNFα, or IL-1 in this study, 
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combinations of three or more species yielded significant correla-
tions with PTB26 especially when T. forsythia, Aa and P. inter-
media were included in the combination. Aa appeared to be a 
necessary co-factor for significant associations of bacterial com-
binations and there is speculation that PTB may be attributed to 
specific genotypes of Aa. F. nucleatum mediates co-aggregation 
of bacterial species by creating an anaerobic environment which 
favors the colonization of the Orange and Red complexes allowing 
for synergistic interaction and increased virulence expression.136
Materials and Methods
Strategy for literature search. PubMed and Science Direct were 
searched for original articles using the following key words: 
adverse pregnancy outcomes OR preterm birth OR low birth-
weight OR pregnancy AND risk factors OR periodontal disease 
OR periodontopathogens OR Red complex OR plaque bacteria 
OR Orange complex.
Inclusion criteria. Studies of the association between sus-
pected periodontopathogens and adverse pregnancy outcomes 
from 1990 through 2011 were included. The search included 
human and animal studies.
Exclusion criteria. The search was limited to reports written 
in English only and excluded pregnancy confounded by other 
systemic illnesses.
Summary and Conclusion
The ultimate aim of this review was to provide evidence for the 
role of periodontal disease-associated Gram-negative anaerobes 
and PTB and to determine whether periodontal treatment could 
reduce the incidence of adverse pregnancy outcomes.
When implicating any specific bacterial species in the etiology 
of PTB, one has to demonstrate its role in ascending infection, 
its ability to elicit maternal and/or fetal antibody responses and 
its ability to produce inflammatory responses such as the produc-
tion of prostaglandins and cytokines as a result of its metabolic 
products or virulence properties. The microbial consortia inves-
tigated have shown an association with, and displayed virulence 
mechanisms for their implication in PTB.
However, a meta-analysis of 44 studies206 found no signifi-
cant association between periodontal disease and PTB, although 
a trend toward association was observed in low-income groups. 
Marked differences were observed in oral microflora between 
subjects from different geographical locations. These population 
differences are, in turn, related to race, lifestyle and socioeco-
nomic conditions, all of which will influence therapeutic out-
comes. Different microbial profiles will demonstrate differences 
in response to therapy thus explaining the different success rates 
of intervention studies.191
A bleeding gingivitis associated with proportional overgrowth 
of Gram-negative anaerobes was found to occur during the sec-
ond trimester of pregnancy47,62 while reduced levels of maternal 
IgG appeared to predict PTB only when assessed in the second 
trimester of pregnancy,102 thus supporting the need for spe-
cific periods of gestation for meaningful microbial assessments. 
inflammatory response leading to elevated levels of IL-6, known 
to be a risk indicator for PTB.194-196 It would also appear that tim-
ing of periodontal treatment dictates the outcome.197 Evidence 
of periodontal treatment being deleterious during pregnancy is 
inconclusive, yet, there is a tendency for dentists to delay dental 
treatment until postpartum because of the risks associated with 
bacteremia, taking of radiographs and drug administration. The 
adverse outcomes associated with delay in treating mothers with 
periodontal disease far out-weigh the perceived complications 
which may occur through immediate action. Thus, if maternal 
periodontal treatment is restricted to the early part of the third 
trimester, with the inclusion of antimicrobial agents, such inter-
vention therapy may reduce adverse pregnancy outcomes.13
However, multicenter intervention studies such as The 
Maternal Oral Therapy to Reduce Obstetric Risk (MOTOR),171 
the Periodontal Infection and Prematurity Study (PIPS)189 and 
the Obstetrics and Periodontal Therapy (OPT) trials172,190 did 
not significantly reduce the rates of adverse pregnancy outcomes 
although the periodontal health of the patients improved. The 
OPT study examined for the Orange and Red complexes along 
with Aa.190 Pregnant women were examined before 21 weeks of 
gestation or postpartum (PTB and FTB). Subgingival plaque 
samples were analyzed using quantitative PCR at baseline and 
post treatment. Although treatment significantly reduced the 
proportions of the Red and Orange complex bacteria, no signifi-
cant difference was observed between PTB and FTB for any of 
the bacteria. Aa levels were not significantly reduced post treat-
ment. Although these studies proved that treatment of periodon-
tal disease during pregnancy was safe and effective, the study 
groups were large and covered general population groups, leav-
ing room for the effect of confounding factors. These results 
contradict smaller studies which showed significant differences 
between PTB and FTB following treatment.186,188 Inconsistencies 
may arise due to population differences, severity of disease, dif-
ferent clonal types of bacterial species as well as differences in the 
management of patients.191
The use of BANA for the screening of mothers at risk for 
PTB due to periodontal disease was recommended by Africa 
et al.73 and confirmed by Chan et al.13 The BANA test is based 
on the principle that members of the Red complex produce a 
trypsin-like enzyme which hydrolyses the substrate benzoyl-DL- 
argenine-naphthylamide (BANA) producing a color change in 
the presence of 104 cell concentrations. Controlling for other risk 
factors, BANA-positive plaques in the third trimester could be 
associated with PTB. The authors thus concluded that BANA 
screening informed the need for intervention between 28–32 
weeks gestation.
Since BANA has been reported to weakly detect 
Capnocytophaga species as well198 BANA-positive plaques in 
the absence of the Red complex could also indicate a risk for 
Capnocytophaga-associated chorioamnionitis.199
Bacterial co-aggregations in biofilms such as plaque are com-
mon, and microbial interactions may modulate their pathogenic 
potential. Examples are P. gingivalis, T. denticola, T. forsythia, 
F. nucleatum, Aa and Campylobacter,200-203 resulting in the 
production of excessive inflammatory responses.204 Bacterial 
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periodontal disease in pregnant women in an effort to prevent 
adverse pregnancy outcomes, while recent studies have indicated 
that the BANA test may be a useful screening tool in identifying 
mothers at risk for PTB13,26,73 and would be worth exploring.
It is reasonable to suggest that infection of the gingiva and 
periodontium by Gram-negative anaerobic bacteria provide 
a reservoir for microbial products (e.g., LPS) and sufficiently 
challenge the host to produce responses which may be deleteri-
ous to both the pregnant mother and the fetus.212 In addition, 
a non-causal correlation between periodontal disease and PTB 
has been hypothesized where hyper-inflammatory response 
to bacterial challenge is genetically determined.213 As demon-
strated in these studies, the association between bacterial colo-
nization and maternal host responses remain speculative. There 
are too many variables to draw any finite conclusions. However, 
the way has been paved for future research to focus on establish-
ing why some women develop adverse pregnancy outcomes due 
to an oral inflammatory burden while others do not. A stan-
dardized universal protocol is needed for the outcomes to be 
conclusive.
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However, periodontal treatment during the second trimester did 
not reduce the risk of adverse pregnancy outcomes.171,172
The strength of an association between two events increases 
the likelihood of a causal relationship. Evidence of the patho-
genic potential of the oral Gram-negative bacilli, the frequent 
association of the Orange and Red complexes with both peri-
odontal disease and PTB and their elimination after intervention 
treatment would suggest a role for them in adverse pregnancy 
outcomes. However, association studies come with their limita-
tions. Confounding variables differ significantly among the dif-
ferent studies with some adjusting for their impact and others 
not. The perceived contradictions of these studies may largely 
be due to the many different definitions of adverse pregnancy 
outcomes205 coupled with differences in gestational ages.11 Some 
researchers sample during the second trimester, while others 
advocate sampling during the third trimester and yet others rec-
ommend postpartum investigations.62,81,98 Selection of different 
diagnostic definitions and measurements of periodontal disease 
states26,51,206-209 will also lead to different outcomes.210 In limiting 
the inflammation source to periodontal disease only, the total 
inflammatory burden from the oral cavity may not be accurately 
assessed.32 One can also argue that these studies examined for a 
select group of oral anaerobes only, which, bearing in mind the 
complexity of the etiology of periodontal diseases, may exclude 
many potential pathogens.
A systematic review of epidemiological studies211 found no 
sound scientific justification to recommend routine screening for 
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